Hemoglobin adducts of the common metabolite of the tobacco-specific nitrosamine (ISNA) 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB) and of4-aminobiphenyl (4-ABP) were quantified in blood samples from smokers and nonsmokers to test their suitability for biomonitoring tobacco smoke exposure. Additionally, ThNA adducts were measured in nasal snuff users. Mild alkaline treatment ofhemoglobin releases 4-ABP and HPB, which were analyzed in parallel by capillary gas chromatography with electronic impact or negative ion chemical-ionization mass spectrometry (El-or NICI-GC-MS). Samples ofsnuff users showed high levels ofHPB adducts not correlated with the amount or type ofsnuffused. HPB concentrations in smokers and nonsmokers, however, were much lower, with no group-specific differences detectable. In contrast, 4-ABP adduct levels were much higher in smokers than in nonsmokers, confirming the significant difference between these two groups reported by others.
Introduction
Upon metabolic activation, constituents of tobacco and tobacco smoke such as the aromatic amine 4-aminobiphenyl (4-ABP) and the tobacco-specific nitrosamines (TSNA) N'-nitrosonornicotine (NNN) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) yield hemoglobin adducts that have been suggested as powerful biomarkers for exposure. Both compound classes are strong animal carcinogens and possibly involved in urinary bladder and lung tumorigenesis of smokers, respectively (1, 2) . Additionally, TSNAareconsideredtobeacausative factor for tumors intheoral cavityofsnuffdippers (1) . Highadductlevels of4-hydroxy-l-(3-pyridyl)-l-butanone (HPB) havebeen detected in hemoglobin samples from snuff dippers. However, the differences between smokers and nonsmokers were not as marked as expected (3). 4-ABP has been considered to be less specific for exposure to tobacco and/or tobacco smoke because ofother possible environmental sources. Nonetheless, ahighly significantdifference was observed in 4-ABP adduct concentrations between smokers and nonsmokers (2). Therefore, it was decided to determine hemoglobin adducts ofboth classes of chemicals to better establish their suitability for biomonitoring tobacco smoke exposure.
Analysis of Human Blood for Hemoglobin Adducts
The protocol as described by Carmella et al. (3) analysis ofadducts formed by aromatic amines, to enable parallel detection ofadducts formedboth by HPB and 4-ABP. The principle ofthe procedure used in our laboratory is outlined in Figure 1 .
To prevent contamination and minimize background values, disposable polypropylene tubes are used for the first steps. After eluting the concentrated solutions from C-18-Bond Elut extraction tubes, only glassware could be used.
Red blood cells were isolated from whole blood by centrifugation and repeated washing with 0.9% NaCI solution. Erythrocytes were hemolyzed by adding three volumes of ice-cold water. After cooling to 0°C for 15 min, 1/3 volume ofphosphate buffer (0.67 m, pH 6.6) was added to adjust ionic strength. Cell membranes were spun down at 18000 rpm (30 min), and the supernatant was dialyzed against water for 48 hr. The resulting hemoglobin solution was frozen at -20°C until analysis.
Before alkaline hydrolysis, the internal standards 4-hy- Acetonitrile was evaporated to dryness under a stream of N2 and the residue derivatized with a mixture of pentafluorobenzoyl chloride (PFBC) and pentafluoropropionic anhydride (PFPA). These reagents are especially suitable for highly selective and sensitive analysis by negative ion chemical ionization (NICI)-GC-MS of HPB and 4-ABP, respectively. After incubation at 60°C for 2 hr the sample was evaporated completely, resuspended in 500 yL ethanol containing pentano-and hexanophenone as retention time markers, and purified by isocratic HPLC (C-18 column, 50% acetonitrile/water, flow rate 0.7 mL/min). The substances eluting between the markers at 12 and 20 min were collected, extracted three times with hexane, and the organic phase concentrated to 20 AL in small glass vials. 
Results and Discussion
The major result of this study is that hemoglobin adducts from two different chemical classes, aromatic amines and nitrosamines, can be determined in a combined analytical pro- cedure. This allows the determination of two independent markers for exposure to tobacco smoke from the same sample. Tests have shown that cross-reactivity of HPB with PFPA and 4-ABP with PFBC is low and does not disturb the analysis of either compound.
The number of analyses done so far is still too small to draw definitive conclusions. As shown in Table 1 , high levels of HPB were detected in the blood from users of nasal snuff. This is in agreement with the results ofCarmella et al. (3) , who found high adduct levels in snuffdippers. The much higher concentrations in snuff dippers as compared to smokers cannot be explained easily by higher uptake ofpreformed NNN and NNK. Because of the rather low TSNA concentrations in nasal snuff from Bavarian manufacturers as compared to different brands of U.S. snuff (5) and the use of rather low amounts of tobacco this difference is even more remarkable in the case of our snuff users.
The lack of significant differences in HPB levels between smokers and nonsmokers confirm the results of Carmella et al. (3) . The reason for the overlapping ofthe adduct values in these groups is not known. Interindividual differences in biotransformation of TSNA or in endogenous TSNA formation from precursor alkaloids are plausible explanations at the moment.
Adducts of4-ABP have been successfully used for biomonitoring the exposure to tobacco smoke (2) . The data in the present study confirm the suitability of this adduct. Future experiments are designed to separate HPB and 4-ABP by HPLC before derivatization, using automatized on-line precolumn enrichment (6) , thus excluding any difficulties that could arise from crossreactivity. In conclusion, we have shown that the simultaneous determination of human hemoglobin adducts arising from aromatic amines as well as from tobacco-specific nitrosamines can be easily accomplished.
